Possibly, patients with already known diabetes, previous insulin therapy, and low baseline HbA1c values are prone to more intensive therapies during hospital admission, favoring hypoglycemia, although this hypothesis should be tested in future studies. The gene discussed is INS; the disease is Hypoglycemia.